6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has allowed foreign…
Pharmaceuticals
Direxion Resuscitates Leveraged Pharmaceutical ETF
Direxion has revived one of its previously shuttered leveraged ETF ideas and increased the stakes on its original design. On Wednesday, Direxion…
Biotech, Pharma ETFs Leave Pricing Drama Behind
Biotechnology and pharmaceutical ETFs have rallied in recent weeks as drug pricing concerns wane and investors look to the opportunity of this…
Drug Makers, Pharma ETFs Face a Tough Earnings Season
The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions…
Alternative ETF Options to Hedge Trump Risk on Obamacare
After Republicans unveiled their Obamacare replacement, healthcare and biotechnology-related sectors were none too pleased. Nevertheless, exchange traded fund investors can still hedge…
Healthcare ETFs Are Latest Victim to Trump
Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect Donald Trump singled out the rising drug…
Rising Rates May Hurt Small-Cap Biotech ETF Valuations
The Federal Reserve has hiked interest rates for the second time in a decade and plans to raise rates three more times…
Trump Bursts Biotech ETFs’ Bubble
Biotechnology stocks and sector-related exchange traded funds retreated Tuesday after President-elect Donald Trump vowed to “bring down drug prices.” The iShares Nasdaq…
Will Trump Make Biotech ETFs Great Again?
Biotechnology exchange traded funds have rebounded after the presidential election and could find further strength under a Donald Trump administration. On the…
Biotech ETFs Unwind Political Risk After Trump Victory
Biotechnology exchange traded funds have rallied on the Donald Trump win and may continue to strengthen as traders retracted months of bearish…
ETF Winners and Losers of President-Elect Trump
Biotechnology and pharmaceutical sector ETFs were the clear winners as Republicans swept the U.S. elections, easing concerns Democrats would implement controls on…
Look to These Sector ETFs in Case of an Election Day Surprise
Heading toward election day, polling surveys and many market watchers anticipate Democrat Hillary Clinton to win the presidential race. However, Republican Donald…
Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO
A pharmaceuticals sector exchange traded fund perked up Friday after Endo International (NasdaqGS: ENDP) Chief Executive Rajiv De Silva stepped aside to…
Biotechnology ETFs Rally on Sarepta FDA Drug Approval
Sarepta Therapeutics (NasdaqGS: SRPT) surged Monday and lifted biotechnology-related exchange traded funds after the Food and Drug Administration approved the Duchenne muscular…